Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Clinical trial NCT02891161 · TERMINATED
Trial details
- NCT number
- NCT02891161
- Sponsor
- Monika Joshi, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2019-08-06
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.